FHIR © HL7.org  |  Server Home  |  FHIR Server FHIR Server 3.7.22-SNAPSHOT  |  FHIR Version n/a  User: [n/a]

425508009: Sitagliptin phosphate (substance)

Status: current, Not sufficiently defined by necessary conditions definition status (core metadata concept). Date: 31-Jul 2007. Module: SNOMED CT core

Descriptions:

Id Description Lang Type Status Case? Module
2661573010 Sitagliptin phosphate (substance) en Fully specified name Active Entire term case insensitive (core metadata concept) SNOMED CT core
2675154010 Sitagliptin phosphate en Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT core
19261000188113 sitagliptine phosphate fr Synonym (core metadata concept) Active Entire term case insensitive (core metadata concept) SNOMED CT Switzerland NRC maintained Module

0 descendants.

Expanded Value Set

Outbound Relationships Type Target Active Characteristic Refinability Group Values
Sitagliptin phosphate (substance) Is a Sitagliptin (substance) false Inferred relationship Some
Sitagliptin phosphate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Dipeptidyl peptidase IV inhibitor (disposition) true Inferred relationship Some
Sitagliptin phosphate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. Sitagliptin (substance) true Inferred relationship Some
Sitagliptin phosphate (substance) Is a Dipeptidyl peptidase IV inhibitor true Inferred relationship Some
Sitagliptin phosphate (substance) Is a Triazole derivative false Inferred relationship Some
Sitagliptin phosphate (substance) Is a Serine proteinase inhibitor false Inferred relationship Some
Sitagliptin phosphate (substance) This attribute specifies the behavior that a substance will exhibit or participate in, given the appropriate context. Serine proteinase inhibitor (disposition) false Inferred relationship Some
Sitagliptin phosphate (substance) Is a Substance with triazole structure (substance) true Inferred relationship Some
Inbound Relationships Type Active Source Characteristic Refinability Group
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Some
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Some
Product containing metformin and sitagliptin (medicinal product) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Some
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Some
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Some
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Some
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Some 1
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Some 1
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Some 1
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Some 2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Sitagliptin phosphate (substance) Inferred relationship Some 2
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The clinically relevant part or whole of the substance that is intended to have a therapeutic action on or within the body. It excludes esters, salts or other non-covalent derivatives (such as a complex, chelate etc.), but may include secondary modifications. False Sitagliptin phosphate (substance) Inferred relationship Some 2
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Sitagliptin phosphate (substance) Inferred relationship Some 2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet This attribute represents an ingredient that is the part of the active ingredient that the strength of a given product is based upon. False Sitagliptin phosphate (substance) Inferred relationship Some 1
Product containing precisely sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sitagliptin phosphate (substance) Inferred relationship Some 1
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Sitagliptin phosphate (substance) Inferred relationship Some 1
Sitagliptin (as sitagliptin phosphate) 25 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sitagliptin phosphate (substance) Inferred relationship Some 1
Product containing precisely metformin hydrochloride 500 milligram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Sitagliptin phosphate (substance) Inferred relationship Some 2
Sitagliptin (as sitagliptin phosphate) 100 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sitagliptin phosphate (substance) Inferred relationship Some 1
Sitagliptin phosphate monohydrate (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Sitagliptin phosphate (substance) Inferred relationship Some
Product containing precisely metformin hydrochloride 1 gram and sitagliptin phosphate 50 milligram/1 each conventional release oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). False Sitagliptin phosphate (substance) Inferred relationship Some 2
Metformin hydrochloride 500 mg and sitagliptin (as sitagliptin phosphate) 50 mg oral tablet The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sitagliptin phosphate (substance) Inferred relationship Some 2
Product containing precisely metformin hydrochloride 850 milligram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sitagliptin phosphate (substance) Inferred relationship Some 2
Product containing precisely metformin hydrochloride 1 gram and sitagliptin (as sitagliptin phosphate) 50 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sitagliptin phosphate (substance) Inferred relationship Some 2
Sitagliptin phosphate anhydrous (substance) This attribute indicates that the concept is a structural modification of another concept, and that the substance's intrinsic physicochemical properties remain unchanged. True Sitagliptin phosphate (substance) Inferred relationship Some
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 5 milligram and sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sitagliptin phosphate (substance) Inferred relationship Some 1
Product containing precisely ertugliflozin (as ertugliflozin pidolate) 15 milligram and sitagliptin (as sitagliptin phosphate) 100 milligram/1 each conventional release oral tablet (clinical drug) The most specific description of a substance present in the manufactured dose form, before any dilution or transformation. It includes modifiers, such as salts, esters, polymers (e.g. pegylation), and/or solvates (including waters of hydration). True Sitagliptin phosphate (substance) Inferred relationship Some 1

This concept is not in any reference sets

Back to Start